Karin holds a Master’s Degree in chemistry from the University of Leipzig, Germany. She has gained a broad clinical expertise in orphan diseases working for companies such as Novartis, Genzyme, BioMarin and Horizon Pharmaceuticals. She has joined Eleva’s team in 2018.